Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...

Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...

Metsera is proving there is still room for the new guy in the GLP-1 world. The seven-month-old startup announced ... based on ...

Metsera is riding the wave of continued enthusiasm for GLP-1 drugs ... 36 days in a phase 1 readout in September. Metsera has ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

potential once-monthly injectable GLP-1 RA engineered with Metsera’s HALO™ lipidation platform. MET-097i showed a 7.5% reduction in body weight from baseline at day 36 and a 380-hour half-life.

She’s maintaining her weight loss on a less-frequent dose of the GLP-1 and is expecting to complete her second marathon at an ...